Prevent Blindness Emphasizes Importance of Sight Care for Older Adults With Cognitive Decline

Posted on July 19, 2019 by Dan Roberts

July 19, 2019

Prevent Blindness Emphasizes Importance of Sight Care for Older Adults With Cognitive Decline

According to the Centers for Disease Control and Intervention (CDC), “Vision impairment often co-occurs with cognitive decline, which can be associated with functional limitations”. Data from Analysis of 2015–2017 Behavioral Risk Factor Surveillance System determined that, “after adjusting for age and other demographic and smoking characteristics, 18% of adults who reported vision impairment also reported […]

Also posted in

Daily Living
Latest News

Stem Cell Treatment for Dry AMD Fast-tracked by FDA

Posted on July 12, 2019July 12, 2019 by Dan Roberts

July 12, 2019

Stem Cell Treatment for Dry AMD Fast-tracked by FDA

It was reported here in March 2017 that BioTime, Inc. is conducting a Phase I/IIa clinical trial for OpRegen® for treatment of dry AMD. OpRegen is a retinal pigment epithelium (RPE) stem cell transplant therapy currently in development for the treatment of dry age-related macular degeneration (AMD) with geographic atrophy (GA). RPE cells are essential […]

Also posted in

Latest News
Research and Developments

The Dangers of Night Driving Glasses

Posted on July 11, 2019 by Dan Roberts

July 11, 2019

The Dangers of Night Driving Glasses

Reprinted courtesy of Laramy-K Optical Lab It is an all too common misconception that yellow tinted or yellow polarized night driving glasses are beneficial for night time driving. The thought is, the yellow or amber color reduces glare and improves contrast. However, in reality, when driving at night or dusk in already limited lighting conditions, […]

Also posted in

Daily Living
Latest News

Correcting 10 Misconceptions About AMD

Posted on June 20, 2019 by Dan Roberts

June 20, 2019

Correcting 10 Misconceptions About AMD

Age-related macular degeneration (AMD) is a progressive disease of the retina wherein the light-sensing cells in the central area of vision (the macula) stop working and eventually die. The disease is thought to be caused by a combination of genetic and environmental factors, and it is most common in people who are age sixty and […]

Also posted in

Charles Bonnet Syndrome Officially Recognized

Posted on June 2, 2019 by Dan Roberts

June 2, 2019

Charles Bonnet Syndrome Officially Recognized

After years of intensive public education efforts about the causes and symptoms of a mysterious hallucinatory condition affecting visually impaired people, Prevent Blindness and other patient advocacy organizations are pleased that Charles Bonnet Syndrome will soon be officially recognized by eye care professionals around the world. As described in the latest revision of the International […]

Also posted in

Eye Conditions
Latest News

Summary of Research and Developments-2019

Posted on May 25, 2019 by Dan Roberts

May 25, 2019

Summary of Research and Developments-2019

This is our 14th annual summary presented to the International Low Vision Support Group about leading research and developments during the past 12 months in the fields of blindness and low vision. Most activity has been in the fields of anti-VEGF treatment and gene replacement therapy. We have also seen promising work with stem cell […]

Also posted in

Latest News
Research and Developments

Why Do More Women Than Men Have AMD?

Posted on May 19, 2019 by Dan Roberts

May 19, 2019

Why Do More Women Than Men Have AMD?

Nearly every reliable resource on age-related macular degeneration (AMD) will reveal that more women than men are affected by the disease. Some even go so far as to offer questionable statistics like “About 2/3 of people with AMD are women and 1/3 men”.(1) To explain, writers offer that women live longer than men, or that […]

Also posted in

Latest News
Research and Developments

Eylea Approved for Diabetic Retinopathy Treatment

Posted on May 14, 2019 by Dan Roberts

May 14, 2019

Eylea Approved for Diabetic Retinopathy Treatment

Regeneron Pharmaceuticals, Inc. has announced FDA approval of Eylea (aflibercept) injection to treat all stages of diabetic retinopathy. Eylea is already approved for treatment of three conditions: neovascular (wet) age-related macular degeneration, macular edema resulting from retinal vein occlusion, and diabetic macular edema. This additional use of Eylea for diabetic retinopathy was approved based upon […]

Also posted in

Latest News
Research and Developments

Need For Improvement in Hospital Care For Vision-Impaired Patients

Posted on May 13, 2019 by Dan Roberts

May 13, 2019

Need For Improvement in Hospital Care For Vision-Impaired Patients

Recent research spotlights a need to address certain risks and incapacities with which people with visual impairment are faced during hospital stays. Vision-impaired hospital patients have worse clinical outcomes, more readmissions, longer lengths of stay, and higher costs of care than non-vision-impaired patients, according to the authors. The article, published April 4, 2019 in JAMA […]

Also posted in

Latest News
Research and Developments

A portable hand-held electronic reader for less than $200

Posted on April 29, 2019 by Dan Roberts

April 29, 2019

A portable hand-held electronic reader for less than $200

Low vision presents many challenges in managing daily living activities, with one of the most important being spot reading. This includes reading labels, instructions, envelope addresses, checkbooks, receipts, menus, food containers, recipes, clocks, signs, written notes, currency values, and on and on. With loss of functional eyesight, such normally routine tasks require either accommodating, seeking […]

Also posted in

Daily Living
Latest News

News & Archive Categories

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in